The survey showed that'COVID-19 has had a major impact on the organization of patient care, on the well-being of caregivers … and on clinical trial activities in oncology,'said a presenter at ESMO 2020.Medscape Medical News (Source: Medscape Medical News Headlines)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
Older adults who take daily low-dose aspirin may be more likely than those who don't to be diagnosed with advanced cancers and to die from them, a randomized trial suggests.Reuters Health Information (Source: Medscape General Surgery Headlines)
Patients aged 75 and older who undergo cancer surgery have lower 90-day postoperative mortality when they receive geriatric co-management than when they don't, a recent study suggests.Reuters Health Information (Source: Medscape General Surgery Headlines)
Stereotactic radiosurgery provides similar overall survival in patients older and younger than 75 years who have brain metastases from lung cancer, according to a retrospective study from Japan.Reuters Health Information (Source: Medscape Radiology Headlines)
Expect another 30 to 40 years of increasing numbers of HPV-related oropharynx cancers, said an expert.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Patients with HR+, HER2- breast cancer at high risk of early recurrence on endothelial therapy could highly improve their invasive disease-free survival with adjuvant abemaciclib, a new trial shows.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
Determining treatment options, as well as the prognosis of patients, may rely on changes in biomarker status during the course of advanced disease progression.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
The combination of lenvatinib and pembrolizumab may extend by more than 1 year the lives of patients with advanced melanoma who progress after immunotherapy, show'important'trial results.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
The drug inhibits KRAS p.G12C-mutant tumors, which are seen in about 13% of patients with non-small cell lung cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
The PD-1 inhibitor/TKI combination is the latest to show superior survival in comparison with sunitinib as first-line therapy for patients with metastatic renal cell carcinoma (RCC).Medscape Medical News (Source: Medscape Urology Headlines)